Search Results - "De Torres, P."

Exertional dyspnoea in patients with mild‐to‐severe chronic obstructive pulmonary disease: neuromechanical mechanisms by James, Matthew D., Phillips, Devin B., Vincent, Sandra G., Abdallah, Sara J., Donovan, Adamo A., de‐Torres, Juan P., Neder, J. Alberto, Smith, Benjamin M., Jensen, Dennis, O'Donnell, Denis E.

“…In patients with chronic obstructive pulmonary disease (COPD), exertional dyspnoea generally arises when there is imbalance between ventilatory demand and…”
Get full text

Severe exacerbations and mortality in COPD: Importance of both body and mind by de‐Torres, Juan P., Divo, Miguel

“…See related article See related article…”
Get full text

The 6-min walk distance in healthy subjects: reference standards from seven countries by CASANOVA, C, CELLI, B. R, PINTO-PLATA, V, AGUIRRE-JAIME, A, BARRIA, P, CASAS, A, COTE, C, DE TORRES, J. P, JARDIM, J, LOPEZ, M. V, MARIN, J. M, MONTES DE OCA, M

“…The 6-min walk distance (6MWD) predicted values have been derived from small cohorts mostly from single countries. The aim of the present study was to…”
Get full text

Similar programmed death ligand 1 (PD-L1) expression profile in patients with mild COPD and lung cancer by Polverino, F., Mirra, D., Yang, C. X., Esposito, R., Spaziano, G., Rojas-Quintero, J., Sgambato, M., Piegari, E., Cozzolino, A., Cione, E., Gallelli, L., Capuozzo, A., Santoriello, C., Berrino, L., de- Torres, J. P., Hackett, T. L., Polverino, M., D’Agostino, B.

“…Programmed Death Ligand 1 (PD-L1) is crucial in regulating the immunological tolerance in non-small cell lung cancer (NSCLC). Alveolar macrophage (AM)-derived…”
Get full text

Reduced exercise tolerance in mild chronic obstructive pulmonary disease: The contribution of combined abnormalities of diffusing capacity for carbon monoxide and ventilatory efficiency by Phillips, Devin B., James, Matthew D., Elbehairy, Amany F., Milne, Kathryn M., Vincent, Sandra G., Domnik, Nicolle J., de‐Torres, Juan P., Neder, J. Alberto, O'Donnell, Denis E.

“…Background and objective The combination of both reduced resting diffusing capacity of the lung for carbon monoxide (DLCO) and ventilatory efficiency…”
Get full text

Identification of COPD Patients at High Risk for Lung Cancer Mortality Using the COPD-LUCSS-DLCO by de-Torres, Juan P., MD, Marín, Jose M., MD, Casanova, Ciro, MD, Pinto-Plata, Victor, MD, Divo, Miguel, MD, Cote, Claudia, MD, Celli, Bartolome R., MD, Zulueta, Javier J., MD

“…Background The COPD-Lung Cancer Screening Score (COPD-LUCSS) is a tool designed to help identify patients with COPD with the highest risk of developing lung…”
Get full text

C-reactive protein levels and clinically important predictive outcomes in stable COPD patients by de Torres, J. P, Cordoba-Lanus, E, Lopez-Aguilar, C, Muros de Fuentes, M, Montejo de Garcini, A, Aguirre-Jaime, A, Celli, B. R, Casanova, C

“…The aim of this study was to determine the relationship between C-reactive protein (CRP) levels and factors known to predict outcome in stable chronic…”
Get full text

Interstitial Lung Abnormalities and Lung Cancer Risk in the National Lung Screening Trial by Whittaker Brown, Stacey-Ann, Padilla, Maria, Mhango, Grace, Powell, Charles, Salvatore, Mary, Henschke, Claudia, Yankelevitz, David, Sigel, Keith, de-Torres, Juan P., Wisnivesky, Juan

“…Some interstitial lung diseases are associated with lung cancer. However, it is unclear whether asymptomatic interstitial lung abnormalities convey an…”
Get full text

The Global Burden of Pulmonary Diseases: Most Prevalent Problems and Opportunities for Improvement by Wisnivesky, Juan, De-Torres, Juan P

“…Diseases of the respiratory system are a leading cause of morbidity, mortality and disability worldwide. The lungs are constantly exposed to a myriad of…”
Get full text

Defining the Asthma-COPD Overlap Syndrome in a COPD Cohort by Cosio, Borja G., MD, Soriano, Joan B., MD, López-Campos, Jose Luis, MD, Calle-Rubio, Myriam, MD, Soler-Cataluna, Juan José, MD, de-Torres, Juan P., MD, Marín, Jose M., MD, Martínez-Gonzalez, Cristina, MD, de Lucas, Pilar, MD, Mir, Isabel, MD, Peces-Barba, Germán, MD, Feu-Collado, Nuria, MD, Solanes, Ingrid, MD, Alfageme, Inmaculada, MD, Casanova, Ciro, MD

“…Background Asthma-COPD overlap syndrome (ACOS) has been recently described by international guidelines. A stepwise approach to diagnosis using usual features…”
Get full text

COPD comorbidities network by Divo, Miguel J, Casanova, Ciro, Marin, Jose M, Pinto-Plata, Victor M, de-Torres, Juan P, Zulueta, Javier J, Cabrera, Carlos, Zagaceta, Jorge, Sanchez-Salcedo, Pablo, Berto, Juan, Davila, Rebeca Baz, Alcaide, Ana B, Cote, Claudia, Celli, Bartolome R

“…Multimorbidity frequently affects the ageing population and their co-existence may not occur at random. Understanding their interactions and that with clinical…”
Get full text

Gender and COPD in patients attending a pulmonary clinic by de Torres, Juan P, Casanova, Ciro, Hernández, Concepción, Abreu, Juan, Aguirre-Jaime, Armando, Celli, Bartolome R

“…To compare gender differences in the clinical expression of COPD patients attending a pulmonary clinic. We compared 53 FEV1-matched men and women with COPD…”
Get more information

Is COPD a Progressive Disease? A Long Term Bode Cohort Observation by de-Torres, Juan P, Marín, Jose M, Pinto-Plata, Víctor, Divo, Miguel, Sanchez-Salcedo, Pablo, Zagaceta, Jorge, Zulueta, Javier J, Berto, Juan, Cabrera, Carlos, Celli, Bartolome R, Casanova, Ciro

“…The Global Initiative for Obstructive Lung Diseases (GOLD) defines COPD as a disease that is usually progressive. GOLD also provides a spirometric…”
Get full text

Comparison of the 2017 and 2015 Global Initiative for Chronic Obstructive Lung Disease Reports. Impact on Grouping and Outcomes by Cabrera López, Carlos, Casanova Macario, Ciro, Marín Trigo, José María, de-Torres, Juan P, Sicilia Torres, Rebeca, González, Jesús María, Polverino, Francesca, Divo, Miguel, Pinto Plata, Víctor, Zulueta, Javier J, Celli, Bartolomé

“…The Global Initiative for Chronic Obstructive Lung Disease (GOLD) document has modified the grading system directing pharmacotherapy, but how this relates to…”
Get full text

Improving selection criteria for lung cancer screening. The potential role of emphysema by Sanchez-Salcedo, Pablo, Wilson, David O, de-Torres, Juan P, Weissfeld, Joel L, Berto, Juan, Campo, Arantzazu, Alcaide, Ana B, Pueyo, Jesús, Bastarrika, Gorka, Seijo, Luis M, Pajares, Maria J, Pio, Ruben, Montuenga, Luis M, Zulueta, Javier J

“…Lung cancer (LC) screening using low-dose chest computed tomography is now recommended in several guidelines using the National Lung Screening Trial (NLST)…”
Get full text

Distance and oxygen desaturation during the 6-min walk test as predictors of long-term mortality in patients with COPD by Casanova, Ciro, Cote, Claudia, Marin, José M, Pinto-Plata, Víctor, de Torres, Juan P, Aguirre-Jaíme, Armando, Vassaux, Carlos, Celli, Bartolome R

“…The distance walked in the 6-min walk test (6MWT) predicts mortality in patients with severe COPD. Little is known about its prognostic value in patients with…”
Get more information

The neutrophil to lymphocyte and platelet to lymphocyte ratios as biomarkers for lung cancer development by Sanchez-Salcedo, Pablo, de-Torres, Juan P, Martinez-Urbistondo, Diego, Gonzalez-Gutierrez, Jessica, Berto, Juan, Campo, Arantzazu, Alcaide, Ana B, Zulueta, Javier J

“…Highlights • Subjects who develop lung cancer have a more pronounced increase in annual NLR and PLR. • Lung cancer incidence density is the highest in those…”
Get full text

Comorbidities and mortality risk in adults younger than 50 years of age with chronic obstructive pulmonary disease by Divo, Miguel J, Marin, José M, Casanova, Ciro, Cabrera Lopez, Carlos, Pinto-Plata, Victor M, Marin-Oto, Marta, Polverino, Francesca, de-Torres, Juan P, Billheimer, Dean, Celli, Bartolome R, Macario, Ciro Casanova, Pinto-Plata, Victor, de-Torres, Juan Pablo, Lopez, Carlos Cabrera, Oto, Marta Marin

“…Rationale and objective Patients with chronic obstructive pulmonary disease (COPD), usually diagnosed after the 6th decade, frequently suffer from…”
Get full text

Chest CT‐assessed comorbidities and all‐cause mortality risk in COPD patients in the BODE cohort by Ezponda, Ana, Casanova, Ciro, Divo, Miguel, Marín‐Oto, Marta, Cabrera, Carlos, Marín, Jose M., Bastarrika, Gorka, Pinto‐Plata, Víctor, Martin‐Palmero, Ángela, Polverino, Francesca, Celli, Bartolome R., Torres, Juan P.

“…Background and objective The availability of chest computed tomography (CT) imaging can help diagnose comorbidities associated with chronic obstructive…”
Get full text

Prevalence and burden of bronchiectasis in a lung cancer screening program by Sanchez-Carpintero Abad, Maria, Sanchez-Salcedo, Pablo, de-Torres, Juan P, Alcaide, Ana B, Seijo, Luis M, Pueyo, Jesus, Bastarrika, Gorka, Zulueta, Javier J, Campo, Arantza

“…The prevalence of bronchiectasis in the general population and in individuals undergoing lung cancer screening with low dose computed tomography (LDCT) is…”
Get full text